Article
Clinical and functional characterisation of a novel TNFRSF1A c.605T>A/V173D cleavage site mutation associated with tumour necrosis factor receptor-associated periodic fever syndrome (TRAPS), cardiovascular complications and excellent response to etanercept treatment.
Annals of the rheumatic diseases - 1 Sept 2008
Stojanov S, Dejaco C, Lohse P, Huss K, Duftner C, Belohradsky B H, Herold M, Schirmer M
Abstract excerpt
OBJECTIVES: To study the clinical outcome, treatment response, T-cell subsets and functional consequences of a novel tumour necrosis factor (TNF) receptor type 1 (TNFRSF1A) mutation affecting the receptor cleavage site. METHODS: Patients with symptoms suggestive of tumour necrosis factor receptor-associated periodic syndrome (TRAPS) and 22 healthy controls (HC) were screened for mutations in the TNFRSF1A gene....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.